TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$162.89 USD
+1.04 (0.64%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $162.88 -0.01 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TMDX 162.89 +1.04(0.64%)
Will TMDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
TransMedics (TMDX) Recently Broke Out Above the 20-Day Moving Average
Can TransMedics (TMDX) Run Higher on Rising Earnings Estimates?
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for August 2nd
Compared to Estimates, TransMedics (TMDX) Q2 Earnings: A Look at Key Metrics
TransMedics (TMDX) Q2 Earnings and Revenues Top Estimates
Other News for TMDX
TransMedics: Strong Execution And Management Conservatism Is A Recipe For Success
Betting Big On TransMedics (Q2 2024 Update)
Here's How Much You Would Have Made Owning TransMedics Gr Stock In The Last 5 Years
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
Q3’s Rising Stars: 3 Growth Stocks for Your Must-Watch List